Drugs / GS-CDA1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00350298 | Jul 2006 → Jun 2008 | Clostridium difficile colitis | MassBiologics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GS-CDA1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00350298 ↗ |
| Action | Inhibit | “two neutralizing, fully human monoclonal antibodies against C. difficile toxins A (CDA1) and B (CDB1).” PMID 20089970 ↗ Jan 2010 |
| Modality | Monoclonal antibody | “a human monoclonal antibody to C. difficile toxin A (GS-CDA1)” NCT00350298 ↗ |